IBO Releases 2012 Instrument Industry Forecast
News Apr 13, 2012
The analytical and life science instrument industry is forecast to grow 5.5% this year to approximately $44.7 billion, according to Strategic Directions International (SDi), a market research and consulting firm that tracks the instrument industry.
The forecast appears in the January 15, 2012, issue of Instrument Business Outlook (IBO).
The market for analytical and life science instruments, which includes aftermarket products and service, increased an estimated 7.1% in 2011, according to SDi.
The special IBO issue features detailed 2012 forecasts, including sales growth and market share information for ten instrument categories: separations techniques, such as HPLC and gas chromatography; life science instruments, including sequencers and microarrays; mass spectrometry; laboratory automation systems; atomic spectroscopy; molecular spectroscopy; surface science techniques, such as microscopy; materials characterization techniques; general analytical techniques; and laboratory equipment.
The issue also includes forecasts for instrument sales by end-user market and region.
Driving instrument sales growth in 2012 will be demand for mass spectrometry and surface science.
Growth in demand from the biotech, food and pharmaceutical industries, as well as independent test labs, particularly CROs, and government and academia, is also expected to stimulate sales.
One in Five Materials Chemistry Papers May be Wrong, Study SuggestsNews
The replicability of results from scientific studies has become a major source of concern in the research community, particularly in the social sciences and biomedical sciences. A new study that compared the results reported in thousands of papers published about the properties of metal organic framework (MOF) materials – which are prominent candidates for carbon dioxide adsorption and other separations – suggests the replicability problem should be a concern for materials researchers, too.READ MORE
Changes Identified in Body Cells During Type2 Diabetes OnsetNews
Researchers have found fresh evidence to explain the processes that occur in the body’s cells leading to the onset of type2 diabetes. Utilising metabolomics, results showed that amino acids play a contributory role in the onset of type2 diabetes in some younger and older patients, as the metabolism of specific amino acids is adversely affected.
Blood Sample Detection Method for Multiple Sclerosis DiscoveredNews
A method for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research team. The process will avoid the invasive, painful process of collecting fluid from the brain and spineREAD MORE